Vadodara, India

Manoj Borsaniya

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Manoj Borsaniya

Introduction

Manoj Borsaniya is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on vortioxetine. His dedication to research and development has led to advancements that benefit the medical community.

Latest Patents

Manoj Borsaniya holds a patent for "Polymorphic forms of vortioxetine and its pharmaceutically acceptable salts." This invention provides novel crystalline forms of vortioxetine and its pharmaceutically acceptable salts. Additionally, it includes an amorphous form of vortioxetine hydrobromide and a stable amorphous co-precipitate of vortioxetine hydrobromide with pharmaceutically acceptable excipients. This patent showcases his commitment to enhancing pharmaceutical formulations.

Career Highlights

Throughout his career, Manoj has focused on innovative solutions in the pharmaceutical industry. His work has not only contributed to the understanding of vortioxetine but has also paved the way for further research in this area. His patent reflects his expertise and dedication to improving drug formulations.

Collaborations

Manoj has collaborated with esteemed colleagues such as Venkat Raman Jayaraman and Sanjiv Tomer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Manoj Borsaniya's contributions to the field of pharmaceuticals through his patent on vortioxetine exemplify his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…